Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting

Anticancer Research

Volumn 30, Issue 4, 2010, Pages 1169-1181

  Corti, Alessandro ^a   Franzini, Maria ^a   Paolicchi, Aldo ^a   Pompella, Alfonso ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Drug resistance; Gamma glutamyltransferase; Human neoplasia; Redox regulation; Review; Tumor progression

Indexed keywords

4 [N (GLUTATHIONYLACETYL)AMINO]PHENYLARSONOUS ACID; 6 DIAZO 5 OXONORLEUCINE; ACIVICIN; ARSENIC ACID DERIVATIVE; AZASERINE; CISPLATIN; CYSTEINE; DOXORUBICIN; FLUOROURACIL; GAMMA GLUTAMYLTRANSFERASE; HYDROGEN PEROXIDE; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; DRUG ACTIVITY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME MECHANISM; ENZYME SPECIFICITY; GLUTATHIONE METABOLISM; HUMAN; LEUKEMIA; MELANOMA; NEPHROTOXICITY; NONHUMAN; OVARY CANCER; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REDOX STRESS; REVIEW; SOFT TISSUE SARCOMA; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DISEASE PROGRESSION; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; NEOPLASMS; OXIDATION-REDUCTION;

EID: 77953783691     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (159)

1. Whitfield JB: Gamma-glutamyltransferase. Crit Rev Clin Lab Sci 38: 263-355, 2001.
2. Lewis RA, Austen KF and Soberman RJ: Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 323: 645-655, 1990.
3. Hogg N, Singh RJ, Konorev E, Joseph J and Kalyanaraman B: 5-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase. Biochem J 323(Pt 2): 477-481, 1997.
4. Meister A, Tate SS and Griffith OW: Gamma-glutamyl transpeptidase. Methods Enzymol 77: 237-253, 1981.
5. Hanigan MH and Frierson HF Jr: Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue. J Histochem Cytochem 44: 1101-1108, 1996. (Pubitemid 26337286)
6. Hanigan MH, Frierson HF Jr, Swanson PE and De Young BR: Altered expression of gamma-glutamyl transpeptidase in human tumors. Hum Pathol 30(3): 300-305, 1999. (Pubitemid 29125150)
7. Pompella A, De Tata V, Paolicchi A and Zunino F: Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance. Biochem Pharmacol 71(3): 231-238, 2006.
8. Paolicchi A, Dominici S, Pieri L, Maellaro E and Pompella A: Glutathione catabolism as a signaling mechanism. Biochem Pharmacol 64(5-6): 1027-1035, 2002.
9. Pompella A, Corti A, Paolicchi A, Giommarelli C and Zunino F: Gamma-glutamyltransferase, redox regulation and cancer drug resistance. Curr Opin Pharmacol 7(4): 360-366, 2007.
10. Dilda PJ, Ramsey EE, Corti A, Pompella A and Hogg PJ: Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino)phenylarsinous acid. J Biol Chem 283(51): 35428-35434, 2008.
11. Roomi MW, Gaal K, Yuan QX, French BA, Fu P, Bardag-Gorce F and French SW: Preneoplastic liver cell foci expansion induced by thioacetamide toxicity in drug-primed mice. Exp Mol Pathol 81(1): 8-14, 2006.
12. Kugelman A, Choy HA, Liu R, Shi MM, Gozal E and Forman HJ: Gamma-glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am J Respir Cell Mol Biol 11: 586-592, 1994.
13. Knickelbein RG, Ingbar DH, Seres T, Snow K, Johnston RB, Jr, Fayemi O, Gumkowski F, Jamieson JD and Warshaw JB: Hyperoxia enhances expression of gamma-glutamyl transpeptidase and increases protein S-glutathiolation in rat lung. Am J Physiol 270: L115-L122, 1996.
14. Liu RM, Shi MM, Giulivi C and Forman HJ: Quinones increase gamma-glutamyl transpeptidase expression by multiple mechanisms in rat lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 274: 330-336, 1998.
15. Borud O, Mortensen B, Mikkelsen IM, Leroy P, Wellman M and Huseby NE: Regulation of gamma-glutamyltransferase in cisplatin-resistant and -sensitive colon carcinoma cells after acute cisplatin and oxidative stress exposures. Int J Cancer 88: 464-468, 2000.
16. Mikkelsen IM, Huseby NE, Visvikis A and Moens U: Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1-binding motif. Biochem Pharmacol 64: 307-315, 2002.
17. Daubeuf S, Duvoix A, Wellman-Rousseau M, Diederich M and Visvikis A: Phorbol ester regulation of the human gamma-glutamyltransferase gene promoter. Biochem Biophys Res Commun 313(2): 300-307, 2004.
18. Zhang H, Liu H, Iles KE, Liu RM, Postlethwait EM, Laperche Y and Forman HJ: 4-Hydroxynonenal induces rat gamma-glutamyl transpeptidase through mitogen-activated protein kinase-mediated electrophile response element/nuclear factor erythroid 2-related factor 2 signaling. Am J Respir Cell Mol Biol 34(2): 174-181, 2006.
19. Pankiv S, Møller S, Bjørkøy G, Moensc U and Huseby NE: Radiation-induced up-regulation of gamma-glutamyltransferase in colon carcinoma cells is mediated through the Ras signal transduction pathway. Biochim Biophys Acta 1760: 151-157, 2006.
20. Pandur S, Pankiv S, Johannessen M, Moens U and Huseby NE: Gamma-glutamyltransferase is up-regulated after oxidative stress through the Ras signal transduction pathway in rat colon carcinoma cells. Free Radic Res 41(12): 1376-1384, 2007.
21. Daubeuf S, Accaoui MJ, Pettersen I, Huseby NE, Visvikis A and Galteau MM: Differential regulation of gamma-glutamyltransferase mRNAs in four human tumour cell lines. Biochim Biophys Acta 1568: 67-73, 2001.
22. Bouman L, Sanceau J, Rouillard D and Bauvois B: Gamma-glutamyl transpeptidase expression in Ewing's sarcoma cells: up-regulation by interferons. Biochem J 364: 719-724, 2002.
23. Reuter S, Schnekenburger M, Cristofanon S, Buck I, Teiten MH, Daubeuf S, Eifes S, Dicato M, Aggarwal BB, Visvikis A and Diederich M: Tumor necrosis factor alpha induces gamma-glutamyltransferase expression via nuclear factor-kappaB in cooperation with Sp1. Biochem Pharmacol 77(3): 397-411, 2009.
24. Hanigan MH, Frierson HF Jr, Brown JE, Lovell MA and Taylor PT: Human ovarian tumors express gamma-glutamyl transpeptidase. Cancer Res 54(1): 286-290, 1994. (Pubitemid 24042125)
25. Murata J, Ricciardi-Castagnoli P, Dessous L'Eglise Mange P, Martin F and Juillerat-Jeanneret L: Microglial cells induce cytotoxic effects toward colon carcinoma cells: measurement of tumor cytotoxicity with a gamma-glutamyl transpeptidase assay. Int J Cancer 70(2): 169-174, 1997.
26. Tsutsumi M, Sakamuro D, Takada A, Zang SC, Furukawa T and Taniguchi N: Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma. Hepatology 23(5): 1093-1097, 1996.
27. Schäfer C, Fels C, Brucke M, Holzhausen HJ, Bahn H, Wellman M, Visvikis A, Fischer P and Rainov NG: Gamma-glutamyl transferase expression in higher-grade astrocytic glioma. Acta Oncol 40(4): 529-535, 2001.
28. Hochwald SN, Rose DM, Brennan MF and Burt ME: Elevation of glutathione and related enzyme activities in high-grade and metastatic extremity soft tissue sarcoma. Ann Surg Oncol 4(4): 303-309, 1997.
29. Supino R, Mapelli E, Sanfilippo O and Silvestro L: Biological and enzymatic features of human melanoma clones with different invasive potential. Melanoma Res 2(5-6): 377-384, 1992. (Pubitemid 23084485)
30. Paolicchi A, Pompella A, Tonarelli P, Gadducci A, Genazzani AR, Zunino F, Pratesi G and Tongiani R: Gamma-glutamyltranspeptidase activity in human ovarian carcinoma. Anticancer Res 16(5B): 3053-3058, 1996.
31. Tager M, Ittenson A, Franke A, Frey A, Gassen HG and Ansorge S: Gamma-glutamyl transpeptidase-cellular expression in populations of normal human mononuclear cells and patients suffering from leukemias. Ann Hematol 70(5): 237-242, 1995.
32. Prezioso JA, Wang N, Duty L, Bloomer WD and Gorelik E: Enhancement of pulmonary metastasis formation and gamma-glutamyltranspeptidase activity in B16 melanoma induced by differentiation in vitro. Clin Exp Metastasis 11(3): 263-274, 1993.
33. Obrador E, Carretero J, Ortega A, Medina I, Rodila V, Pellicer JA and Estrema JM: Gamma-glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Hepatology 35: 74-81, 2002.
34. Bard S, Noël P, Chauvin F and Quash G: Gamma-glutamyltranspeptidase activity in human breast lesions: an unfavourable prognostic sign. Br J Cancer 53(5): 637-642, 1986. (Pubitemid 16114624)
35. Frierson HF Jr, Theodorescu D, Mills SE and Hanigan MH: Gamma-glutamyl transpeptidase in normal and neoplastic prostate glands. Mod Pathol 10(1): 1-6, 1997.
36. Ozdemirler G, Pabuççuoglu H, Bulut T, Bugra D, Uysal M and Toker G: Increased lipoperoxide levels and antioxidant system in colorectal cancer. J Cancer Res Clin Oncol 124(10): 555-559, 1998.
37. Durham JR, Frierson HF Jr and Hanigan MH: Gamma-glutamyl transpeptidase immunoreactivity in benign and malignant breast tissue. Breast Cancer Res Treat 45(1): 55-62, 1997.
38. Hanigan MH and Pitot HC: Gamma-glutamyl transpeptidase-its role in hepatocarcinogenesis. Carcinogenesis 6(2): 165-172, 1985.
39. Sze G, Kaplowitz N, Ookhtens M and Lu SC: Bidirectional membrane transport of intact glutathione in Hep G2 cells. Am J Physiol 265(6 Pt 1): G1128-1134, 1993.
40. Kang YJ, Feng Y and Hatcher EL: Glutathione stimulates A549 cell proliferation in glutamine-deficient culture: the effect of glutamate supplementation. J Cell Physiol 161: 589-596, 1994.
41. Lieberman MW, Wiseman AL, Shi ZZ, Carter BZ, Barrios R, Ou CN, Chévez-Barrios P, Wang Y, Habib GM, Goodman JC, Huang SL, Lebovitz RM and Matzuk MM: Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci USA 93(15): 7923-7926, 1996.
42. Rajpert-De Meyts E, Shi M, Chang M, Robison TW, Groffen J, Heisterkamp N and Forman HJ: Transfection with gamma-glutamyl transpeptidase enhances recovery from glutathione depletion using extracellular glutathione. Toxicol Appl Pharmacol 114(1): 56-62, 1992.
43. Hanigan MH: Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine. Carcinogenesis 16: 181-185, 1995.
44. Hochwald SN, Harrison LE, Rose DM, Anderson M and Burt ME: Gamma-glutamyl transpeptidase mediation of tumor glutathione utilization in vivo. J Natl Cancer Inst 88: 193-197, 1996.
45. Hanigan MH, Gallagher BC, Townsend DM and Gabarra V: Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis 20(4): 553-559, 1999.
46. Franzini M, Corti A, Lorenzini E, Paolicchi A, Pompella A, De Cesare M, Perego P, Gatti L, Leone R, Apostoli P and Zunino F: Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells. Eur J Cancer 42(15): 2623-2630, 2006.
47. Ruoso P and Hedley DW: Inhibition of gamma-glutamyl transpeptidase activity decreases intracellular cysteine levels in cervical carcinoma. Cancer Chemother Pharmacol 54(1): 49-56, 2004.
48. 2-induced injury by 2,3-dimethoxy-1,4-naphthoquinone. Free Rad Biol Med 15: 57-67, 1993.
49. Hochwald SN, Rose DM, Brennan MF and Burt ME: Elevation of glutathione and related enzyme activities in high-grade and metastatic extremity soft tissue sarcoma. Ann Surg Oncol 4(4): 303-309, 1997.
50. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC and Anderson ME: High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89(7): 3070-3074, 1992.
51. Mares V, Lisa V, Malik R, Kozakova H and Sedo A: Cisplatin induced gamma-glutamyltransferase up-regulation, hypertrophy and differentiation in astrocytic glioma cells in culture. Histol Histopathol 18: 687-693, 2003. (Pubitemid 36773212)
52. Lewis AL, Hayes JD and Wolf CR: Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects. Carcinogenesis 9: 1283-1287, 1988.
53. Benlloch M, Ortega A, Ferrer P, Segarra R, Obrador E, Asensi M, Carretero J and Estrela JM: Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity. J Biol Chem 280: 6950-6959, 2005.
54. Bailey HH, Gipp JJ and Mulcahy RT: Increased expression of gamma-glutamyl transpeptidase in transfected tumor cells and its relationship to drug sensitivity. Cancer Lett 87: 163-170, 1994.
55. Karp DR, Shimooku K and Lipsky PE: Expression of gamma-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. J Biol Chem 276(6): 3798-3804, 2001.
56. Warren BS, Naylor MF, Winberg LD, Yoshimi N, Volpe JP, Gimenez-Conti I and Slaga TJ: Induction and inhibition of tumor progression. Proc Soc Exp Biol Med 202(1): 9-15, 1993.
57. Manzotti C, Pratesi G, Menta E, Di Domenico R, Cavalletti E, Fiebig HH, Kelland LR, Farrell N, Polizzi D, Supino R, Pezzoni G and Zunino F: BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin. Clin Cancer Res 6(7): 2626-2634, 2000.
58. Paolicchi A, Lorenzini E, Perego P, Supino R, Zunino F, Comporti M and Pompella A: Extracellular thiol metabolism in clones of human metastatic melanoma with different gamma-glutamyl transpeptidase expression: implications for cell response to platinum-based drugs. Int J Cancer 97(6): 740-745, 2002.
59. Perego P, Romanelli S, Carenini N, Magnani I, Leone R, Bonetti A, Paolicchi A and Zunino F: Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol. Ann Oncol 9(4): 423-430, 1998.
60. Pratesi G, Dal Bo L, Paolicchi A, Tonarelli P, Tongiani R and Zunino F: The role of the glutathione-dependent system in tumor sensitivity to cisplatin: a study of human tumor xenografts. Ann Oncol 6: 283-289, 1995.
61. Hanigan MH, Frierson HF Jr, Abeler VM, Kaern J and Taylor PT Jr: Human germ cell tumours: expression of gamma-glutamyl transpeptidase and sensitivity to cisplatin. Br J Cancer 81(1): 75-79, 1999.
62. Kröning R, Lichtenstein AK and Nagami GT: Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubule epithelial cell lines. Cancer Chemother Pharmacol 45: 43-49, 2000. (Pubitemid 30099714)
63. Zimmermann T, Zeizinger M and Burda JV: Cisplatin interaction with cysteine and methionine, a theoretical DFT study. J Inorg Biochem 99(11): 2184-2196, 2005.
64. Paolicchi A, Sotiropuolou M, Perego P, Daubeuf S, Visvikis A, Lorenzini E, Franzini M, Romiti N, Chieli E, Leone R, Apostoli P, Colangelo D, Zunino F and Pompella A: Gamma-glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney. Eur J Cancer 39: 96-103, 2003.
65. Jerremalm E, Wallin I, Yachnin J and Ehrsson H: Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate. Eur J Pharm Sci 28(4): 278-283, 2006.
66. Daubeuf S, Leroy P, Paolicchi A, Pompella A, Wellman M, Galteau MM and Visvikis A: Enhanced resistance of HeLa cells to cisplatin by overexpression of gamma-glutamyltransferase. Biochem Pharmacol 64: 207-216, 2002.
67. Stark AA, Arad A, Siskindovich S, Pagano DA and Zeiger E: Effect of pH on mutagenesis by thiols in Salmonella typhimurium TA102. Mutat Res 224(1): 89-94, 1989.
68. Pinzani V, Bressolle F, Haug IJ, Galtier M, Blayac JP and Balmès P: Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemother Pharmacol 35(1): 1-9, 1994.
69. Arany I and Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol 23(5): 460-464, 2003.
70. Zhang L and Hanigan MH: Role of cysteine 5-conjugate beta-lyase in the metabolism of cisplatin. J Pharmacol Exp Ther 306(3): 988-994, 2003.
71. Hanigan MH, Lykissa ED, Townsend DM, Ou CN, Barrios R and Lieberman MW: Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin. Am J Pathol 159(5): 1889-1894, 2001.
72. Hanigan MH, Gallagher BC, Taylor PT Jr and Large MK: Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. Cancer Res 54(22): 5925-5929, 1994.
73. Townsend DM and Hanigan MH: Inhibition of gamma-glutamyl transpeptidase or cysteine 5-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice. J Pharmacol Exp Ther 300(1): 142-148, 2002.
74. Wainford RD, Weaver RJ, Stewart KN, Brown P and Hawksworth GM: Cisplatin nephrotoxicity is mediated by gamma-glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway. Toxicology 249(2-3): 184-193, 2008.
75. Zunino F, Pratesi G, Micheloni A, Cavalletti E, Sala F and Tofanetti O: Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chem Biol Interact 70(1-2): 89-101, 1989.
76. Bernareggi A, Torti L, Facino RM, Carini M, Depta G, Casetta B, Farrell N, Spadacini S, Ceserani R and Tognella S: Characterization of cisplatin-glutathione adducts by liquid chromatography-mass spectrometry. Evidence for their formation in vitro but not in vivo after concomitant administration of cisplatin and glutathione to rats and cancer patients. J Chromatogr B Biomed Appl 669(2): 247-263, 1995.
77. Griffith OW and Meister A: Translocation of intracellular glutathione to membrane-bound gamma-glutamyltranspeptidase as a discrete step in the gamma-glutamyl cycle: glutathionuria after inhibition of transpeptidase. Proc Natl Acad Sci USA 76: 268-272, 1979.
78. Lieberman MW, Wiseman AL, Shi ZZ, Carter BZ, Barrios R, Ou CN, Chévez-Barrios P, Wang Y, Habib GM, Goodman JC, Huang SL, Lebovitz RM and Matzuk MM: Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci USA 93: 7923-7926, 1996.
79. Meister A: Metabolism and transport of glutathione and other gamma-glutamyl compounds. In: Larsson A, Orrenius S, Holmgren A and Mannervik B (ed.). Functions of Glutathione: Biochemical, Toxicological and Clinical Aspects. New York: Raven Press, pp. 1-22, 1983.
80. Dedon PC and Borch RF: Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles. Biochem Pharmacol 36(12): 1955-1964, 1987.
81. Ishikawa T and Ali-Osman F: Glutathione-associated cis- diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J Biol Chem 268(27): 20116-20125, 1993.
82. Heudi O, Brisset H, Cailleux A and Allain P: Chemical instability and methods for measurement of cisplatin adducts formed by interactions with cysteine and glutathione. Int J Clin Pharmacol Ther 39(8): 344-349, 2001. (Pubitemid 32707812)
83. Townsend DM, Marto JA, Deng M, Macdonald TJ and Hanigan MH: High pressure liquid chromatography and mass spectrometry characterization of the nephrotoxic biotransformation products of Cisplatin. Drug Metab Dispos 31(6): 705-713, 2003. (Pubitemid 36617657)
84. Townsend DM, Deng M, Zhang L, Lapus MG and Hanigan MH: Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol 14(1): 1-10, 2003.
85. Spear N and Aust SD: Thiol-mediated NTA-Fe(III) reduction and lipid peroxidation. Arch Biochem Biophys 312(1): 198-202, 1994.
86. Stark AA, Russel JJ, Langenbach R, Pagano DA, Zeiger E and Huberman E: Localization of oxidative damage by a glutathione-gamma-glutamyl transpeptidase system in preneoplastic lesions in sections of livers from carcinogen-treated rats. Carcinogenesis 15: 343-348, 1994. (Pubitemid 24121672)
87. Stark AA, Zeiger E and Pagano DA: Glutathione mutagenesis in Salmonella typhimurium is a gamma-glutamyltranspeptidase-enhanced process involving active oxygen species. Carcinogenesis 9(5): 771-777, 1988.
88. Stark AA and Glass GA: Role of copper and ceruloplasmin in oxidative mutagenesis induced by the glutathione-gamma-glutamyl transpeptidase system and by other thiols. Environ Mol Mutagen 29(1): 63-72, 1997.
89. 2 production and S-thiolation. Free Radic Biol Med 27(5-6): 623-635, 1999.
90. Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G and Wellman M: Gamma-glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 25(7): 786-792, 1998.
91. Del Bello B, Paolicchi A, Comporti M, Pompella A and Maellaro E: Hydrogen peroxide produced during gamma-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintainance of proliferation in U937 cells. FASEB J 13(1): 69-79, 1999.
92. Dominici S, Paolicchi A, Lorenzini E, Maellaro E, Comporti M, Pieri L, Minotti G and Pompella A: Gamma-glutamyltransferase-dependent prooxidant reactions: a factor in multiple processes. Biofactors 17(1-4): 187-198, 2003.
93. Pompella A, Paolicchi A, Dominici S, Comporti M and Tongiani R: Selective colocalization of lipid peroxidation and protein thiol loss in chemically induced hepatic preneoplastic lesions: the role of gamma-glutamyltranspeptidase activity. Histochem Cell Biol 106(3): 275-282, 1996.
94. Paolicchi A, Tongiani R, Tonarelli P, Comporti M and Pompella A: Gamma-glutamyl transpeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells. Free Radic Biol Med 22(5): 853-860, 1997.
95. Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, Dominici S, Comporti M and Pompella A: Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation - a potential mechanism in atherosclerosis. J Investig Med 47(3): 151-160, 1999.
96. Corti A, Duarte TL, Giommarelli C, De Tata V, Paolicchi A, Jones GD and Pompella A: Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells. Mutat Res 669(1-2): 112-121, 2009
97. Corti A, Raggi C, Franzini M, Paolicchi A, Pompella A and Casini AF: Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells. Free Radic Biol Med 37(11): 1906-1915, 2004.
98. Glass GA and Stark AA: Promotion of glutathione-gamma-glutamyl transpeptidase-dependent lipid peroxidation by copper and ceruloplasmin: the requirement for iron and the effects of antioxidants and antioxidant enzymes. Environ Mol Mutagen 29(1): 73-80, 1997.
99. Dominici S, Pieri L, Comporti M and Pompella A: Possible role of membrane gamma-glutamyltransferase activity in the facilitation of transferrin-dependent and -independent iron uptake by cancer cells. Cancer Cell Int 3(1): 7-14, 2003.
100. Toyokuni S, Okamoto K, Yodoi J and Hiai H: Persistent oxidative stress in cancer. FEBS Lett 358(1): 1-3, 1995.
101. Sen CK: Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 55(11): 1747-1758, 1998.
102. Cotgreave IA and Gerdes RG: Recent trends in glutathione biochemistry-glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation? Biochem Biophys Res Commun 242(1): 1-9, 1998.
103. 2 production, cell surface protein thiol oxidation and NF-κB activation status. J Cell Sci 113: 2671-2678, 2000.
104. Corti A, Paolicchi A, Franzini M, Dominici S, Casini AF and Pompella A: The S-thiolating activity of membrane gamma-glutamyltransferase: formation of cysteinyl-glycine mixed disulfides with cellular proteins and in the cell microenvironment. Antioxid Redox Signal 7(7-8): 911-918, 2005.
105. Dominici S, Pieri L, Paolicchi A, De Tata V, Zunino F and Pompella A: Endogenous oxidative stress induces distinct redox forms of tumor necrosis factor receptor-1 in melanoma cells. Ann NY Acad Sci 1030: 62-68, 2004.
106. Accaoui MJ, Enoiu M, Mergny M, Masson C, Dominici S, Wellman M and Visvikis A: Gamma-glutamyltranspeptidase-dependent glutathione catabolism results in activation of NF-κB. Bioch Biophys Res Commun 276: 1062-1067, 2000.
107. Dominici S, Visvikis A, Pieri L, Paolicchi A, Valentini M, Comporti M and Pompella A: Redox modulation of NF-κB nuclear translocation and DNA binding in metastatic melanoma - the role of endogenous and gamma- glutamyltransferase-dependent oxidative stress. Tumori 89: 428-435, 2003.
108. Paolicchi A, Dominici S, Pieri L, Maellaro E and Pompella A: Glutathione catabolism as a signaling mechanism. Biochem Pharmacol 64: 1027-1035, 2002.
109. 2 production. Biochim Biophys Acta 1621(1): 76-83, 2003.
110. Suzuki YJ, Forman HJ and Sevanian A: Oxidants as stimulators of signal transduction. Free Rad Biol Med 22: 269-285, 1997.
111. Perego P, Paolicchi A, Pompella A, Carenini N, Romanelli S and Zunino F: The cell-specific antiproliferative effect of reduced glutathione is mediated by gamma-glutamyl transpeptidase dependent extracellular prooxidant reactions. Int J Cancer 71: 246-250, 1997.
112. Giommarelli C, Corti A, Supino R, Favini E, Paolicchi A, Pompella A and Zunino F: Cellular response to oxidative stress and ascorbic acid in melanoma cells overexpressing gamma-glutamyltransferase. Eur J Cancer 44(5): 750-759, 2008.
113. Tate SS and Meister A: Serine-borate complex as a transition-state inhibitor of gamma-glutamyl transpeptidase. Proc Natl Acad Sci USA 75(10): 4806-4809, 1978.
114. Allen L, Meck R and Yunis A: The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501). Res Commun Chem Pathol Pharmacol 27(1): 175-182, 1980.
115. London RE and Gabel SA: Development and evaluation of a boronate inhibitor of gamma-glutamyl transpeptidase. Arch Biochem Biophys 385(2): 250-258, 2001.
116. Lherbet C, Gravel C and Keillor JW: Synthesis of S-alkyl L-homocysteine analogues of glutathione and their kinetic studies with gamma-glutamyl transpeptidase. Bioorg Med Chem Lett 14(13): 3451-3455, 2004.
117. Han L, Hiratake J, Kamiyama A and Sakata K: Design, synthesis, and evaluation of gamma-phosphono diester analogues of glutamate as highly potent inhibitors and active site probes of gamma-glutamyl transpeptidase. Biochemistry 46(5): 1432-1447, 2007.
118. Ahluwalia GS, Grem JL, Hao Z and Cooney DA: Metabolism and action of amino acid analog anticancer agents. Pharmacol Ther 46(2): 243-271, 1990.
119. Lyons SD, Sant ME and Christopherson RI: Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia. J Biol Chem 265(19): 11377-11381, 1990. (Pubitemid 20200150)
120. Mena S, Benlloch M, Ortega A, Carretero J, Obrador E, Asensi M, Petschen I, Brown BD and Estrela JM: Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease. Clin Cancer Res 13(9): 2658-2666, 2007.
121. King JB, West MB, Cook PF and Hanigan MH: A novel, species-specific class of uncompetitive inhibitors of gamma-glutamyl transpeptidase. J Biol Chem 284(14): 9059-9065, 2009.
122. Giommarelli C, Corti A, Supino R, Favini E, Paolicchi A, Pompella A and Zunino F: Gamma-glutamyltransferase-dependent resistance to arsenic trioxide in melanoma cells and cellular sensitization by ascorbic acid. Free Radic Biol Med 46(11): 1516-1526, 2009.
123. Teicher BA: Hypoxia and drug resistance. Cancer Metastasis Rev 13(2): 139-168, 1994.
124. Sullivan R and Graham CH: Chemosensitization of cancer by nitric oxide. Curr Pharm Des 14(11): 1113-1123, 2008.
125. Frederiksen LJ, Sullivan R, Maxwell LR, Macdonald-Goodfellow SK, Adams MA, Bennett BM, Siemens DR and Graham CH: Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling. Clin Cancer Res 13(7): 2199-2206, 2007.
126. Weyerbrock A, Baumer B and Papazoglou A: Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro. J Neurosurg 110(1): 128-136, 2009.
127. Adams C, McCarthy HO, Coulter JA, Worthington J, Murphy C, Robson T and Hirst DG: Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells. J Gene Med 11(2): 160-168, 2009.
128. Bramanti E, Angeli V, Franzini M, Vecoli C, Baldassini R, Paolicchi A, Barsacchi R and Pompella A: Exogenous vs. endogenous gamma-glutamyltransferase activity: Implications for the specific determination of S-nitrosoglutathione in biological samples. Arch Biochem Biophys 487: 146-152, 2009.
129. Donoghue N, Yam PT, Jiang XM and Hogg PJ: Presence of closely spaced protein thiols on the surface of mammalian cells. Protein Sci 9(12): 2436-2445, 2000. (Pubitemid 32105726)
130. Don AS, Kisker O, Dilda P, Donoghue N, Zhao X, Decollogne S, Creighton B, Flynn E, Folkman J and Hogg PJ: A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells. Cancer Cell 3(5): 497-509, 2003.
131. Dilda PJ, Don AS, Tanabe KM, Higgins VJ, Allen JD, Dawes IW and Hogg PJ: Mechanism of selectivity of an angiogenesis inhibitor from screening a genome-wide set of Saccharomyces cerevisiae deletion strains. J Natl Cancer Inst 97(20): 1539-1547, 2005.
132. Dilda PJ, Decollogne S, Rossiter-Thornton M and Hogg PJ: Para to Ortho repositioning of the arsenical moiety of the angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino) nphenylarsenoxide results in a markedly increased cellular accumulation and antiproliferative activity. Cancer Res 65(24): 11729-11734, 2005.
133. Kinlough CL, Poland PA, Bruns JB and Hughey RP: Gamma- glutamyltranspeptidase: disulfide bridges, propeptide cleavage, and activation in the endoplasmic reticulum. Meth Enzymol 401: 426-449, 2005.
134. Niida S, Kawahara M, Ishizuka Y, Ikeda Y, Kondo T, Hibi T, Suzuki Y, Ikeda K and Taniguchi N: Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor. J Biol Chem 279: 5752-5756, 2004.
135. Hiramatsu K, Asaba Y, Takeshita S, Nimura Y, Tatsumi S, Katagiri N, Niida S, Nakajima T, Tanaka S, Ito M, Karsenty G and Ikeda K: Overexpression of gamma-glutamyltransferase in transgenic mice accelerates bone resorption and causes osteoporosis. Endocrinology 148(6): 2708-2715, 2007.
136. Asaba Y, Hiramatsu K, Matsui Y, Harada A, Nimura Y, Katagiri N, Kobayashi T, Takewaka T, Ito M, Niida S and Ikeda K: Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption. Bone 39(6): 1276-1282, 2006.
137. Emdin M, Passino C, Pompella A and Paolicchi A: Gamma-glutamyltransferase as a cardiovascular risk factor. Eur Heart J 27(18): 2145-2146, 2006.
138. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE and Steffes M: Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49(8): 1358-1366, 2003. (Pubitemid 36900623)
139. Lee DH, Silventoinen K, Jacobs DR Jr, Jousilahti P and Tuomileto J: Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab 89(11): 5410-5414, 2004.
140. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB and Vasan RS: Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27(1): 127-133, 2007.
141. Ryu S, Chang Y, Kim DI, Kim WS and Suh BS: Gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 53: 71-77, 2007.
142. Kazemi-Shirazi L, Endler G, Winkler S, Schickbauer T, Wagner O and Marsik C: Gamma-glutamyltransferase and long-term survival: is it just the liver? Clin Chem 53: 940-946, 2007.
143. Xu K, Meng XY, Wu JW, Shen B, Shi YC and Wei Q: Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study. Am J Gastroenterol 87(8): 991-995, 1992.
144. Yao DF, Huang ZW, Chen SZ, Huang JF, Lu JX, Xiao MB and Meng XY: Diagnosis of hepatocellular carcinoma by quantitative detection of hepatoma-specific bands of serum gamma-glutamyltransferase. Am J Clin Pathol 110(6): 743-749, 1998.
145. Castaldo G, Intrieri M, Castellano L, de Sio I, Del Vecchio Blanco C, Sacchetti L and Salvatore F: Serum gamma-glutamyltransferase isoform complexed to LDL in the diagnosis of small hepatocellular carcinoma. Clin Chem 45(7): 1100-1102, 1999.
146. Franzini M, Corti A, Fornaciari I, Balderi M, Torracca F, Lorenzini E, Baggiani A, Pompella A, Emdin M and Paolicchi A: Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT. Biomarkers 14(7): 486-492, 2009.
147. Huseby NE and Eide TJ: Variant gamma-glutamyltransferase in colorectal carcinoma and liver metastasis. A case study. Clin Biochem 18(4): 217-219, 1985.
148. Yamashita K, Totani K, Iwaki Y, Takamisawa I, Tateishi N, Higashi T, Sakamoto Y and Kobata A: Comparative study of the sugar chains of gamma-glutamyltranspeptidases purified from human hepatocellular carcinoma and from human liver. J Biochem 105(5): 728-735, 1989.
149. Arai K, Yoshida K, Komoda T, Kobayashi N and Sakagishi Y: Differences in the enzymatic nature and the sugar-chain structure of gamma-glutamyl transferase between normal and carcinomatous human kidney and prostate. Clin Chim Acta 210(1-2): 35-46, 1992.
150. Li X, Mortensen B, Rushfeldt C and Huseby NE: Serum gamma- glutamyltransferase and alkaline phosphatase during experimental liver metastases. Detection of tumour-specific isoforms and factors affecting their serum levels. Eur J Cancer 34(12): 1935-1940, 1998.
151. Yao D, Jiang D, Huang Z, Lu J, Tao Q, Yu Z and Meng X: Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. Cancer 88(4): 761-769, 2000.
152. Yao DF, Dong ZZ, Yao DB, Wu XH, Wu W, Qiu LW, Wang HM and Meng XY: Abnormal expression of hepatoma-derived gamma-glutamyltransferase subtyping and its early alteration for carcinogenesis of hepatocytes. Hepatobiliary Pancreat Dis Int 3(4): 564-570, 2004.
153. Pettersen I, Andersen JA, Bjornland K, Mathisen Ø, Bremnes R, Wellman M, Visvikis A and Huseby NE: Heterogeneity in gamma-glutamyltransferase mRNA expression and glycan structures. Search for tumor-specific variants in human liver metastases and colon carcinoma cells. Biochim Biophys Acta 1648: 210-218, 2003.
154. Sandock DS, Seftel AD and Resnick MI: The role of gamma-glutamyl transpeptidase in the preoperative metastatic evaluation of renal cell carcinoma. J Urol 157: 798-799, 1997.
155. Simic T, Dragicevic D, Savic-Radojevic A, Cimbaljevic S, Tulic C and Mimic-Oka J: Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma. Int J Urol 14(4): 289-293, 2007.
156. Morsi MI, Hussein AE, Mostafa M, El-Abd E and El-Moneim NA: Evaluation of tumour necrosis factor-alpha, soluble P-selectin, gamma-glutamyl transferase, glutathione S-transferase-pi and alpha-fetoprotein in patients with hepatocellular carcinoma before and during chemotherapy. Br J Biomed Sci 63(2): 74-78, 2006.
157. Melezínek I, Borovanský J, Elleder M and Bubnová E: Tumour tissue is a source of gamma-glutamyl transpeptidase sialoform in the sera of melanoma-bearing mice. Melanoma Res 8(1): 39-45, 1998.
158. Strasak AM, Rapp K, Brant LJ, Hilbe W, Gregory M, Oberaigner W, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H and the VHM&PP Study Group: Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res 68(10): 3970-3977, 2008.
159. Strasak AM, Pfeiffer RM, Klenk J, Hilbe W, Oberaigner W, Gregory M, Concin H, Diem G, Pfeiffer KP, Ruttmann E, Ulmer H and Vorarlberg Health Monitoring and Promotion Program Study Group: Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women. Int J Cancer 123(8): 1902-1906, 2008.